8C
Delhi
Wednesday, January 27, 2021

WHO approves Pfizer Covid-19 vaccine for emergency use

- Advertisement -

Pfizer Covid-19 vaccine wins crucial approval as US cases soarGeneva, Jan 1 (IANS) The World Health Organization (WHO) has granted emergency use validation for the Pfizer-BioNTech Covid-19 vaccine, opening the door for countries to expedite their own regulatory approval processes to import and administer the vaccine.

While many countries rely on their own regulatory systems for vaccine approvals, some countries with weak system depend on WHO’s nod to a great extent for rolling out their national vaccination programmes.

The WHO’s emergency validation also enables Unicef and the Pan-American Health Organization to procure the vaccine for distribution to countries in need, the UN health agency said on Thursday.

Several countries including the US and the UK have already approved the Pfizer-BioNTech Covid-19 vaccine.

This is the first time WHO has granted emergency validation to a Covid-19 vaccine since the outbreak began a year ago.

READ ALSO:  COVID 2019: Cases in India reached 125, Yogi warns strict action on refusing test

“This is a very positive step towards ensuring global access to Covid-19 vaccines. But I want to emphasise the need for an even greater global effort to achieve enough vaccine supply to meet the needs of priority populations everywhere,” Mariangela Simao, WHO Assistant-Director General for Access to Medicines and Health Products, said in a statement.

The WHO noted that the vaccine requires storage using an ultra-cold chain — it needs to be stored at minus 60 degree C to minus 90 degree C.

This requirement makes the vaccine more challenging to deploy in settings where ultra-cold chain equipment may not be available or reliably accessible.

READ ALSO:  IGI starts on demand Covid testing for all passengers

For that reason, WHO is working to support countries in assessing their delivery plans and preparing for use where possible.

“WHO and our partners are working night and day to evaluate other vaccines that have reached safety and efficacy standards. We encourage even more developers to come forward for review and assessment.”

Regulatory experts convened by WHO from around the world and WHO’s own teams reviewed the data on the Pfizer-BioNTech vaccine’s safety, efficacy and quality as part of a risk-versus-benefit analysis.

READ ALSO:  Coronavirus set to derail Indian mobile industry by mid-March

The review found that the vaccine met the must-have criteria for safety and efficacy set out by WHO, and that the benefits of using the vaccine to address Covid-19 offset potential risks.

Source: IANS

India Updates
India Updates is an independent news & Information website. Follow us for regular updates on News and Information.

Follow Us On

Related News

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Trending Topics In India

Covid 19 India Updates

Trending News In India

Trending Showbiz

Trending Sports

Latest Trending News In India

Delhi Police caught off guard by breach of trust by protesters?

New Delhi, Jan 26 (IANS) When the Delhi police entered into an agreement with the protesting farmers, little did they realise there were chances...

How the situation turned ugly at Red Fort

New Delhi, Jan 26 (IANS) The farmers movement that had been peaceful for the last two months turned violent on Republic Day on Tuesday...

Anyone who wants Covid vaccine could get it ‘this Spring’: Biden

By Nikhila Natarajan (IANS) US President Joe Biden's underpromise-overdeliver strategy on Covid-19 vaccine allocation landed its most optimistic message yet, pointing to vaccination for...

SKM asks farmers to return to borders, continue peaceful protest

New Delhi, Jan 26 (IANS): After violent clashes with between the police and the protesting farmers in the national capital on Tuesday, the Samyukt Kisan...